Nadunolimab

Tax included
Nadunolimab is a human monoclonal IgG1 antibody targeting IL1RAP. Nadunolimab blocks IL-1α and IL-1β signaling and triggering antibody-dependent cellular cytotoxicity. Nadunolimab can be used in research of cancer.
MedChemExpress 
HY-P99235

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
Application
Cancer-programmed cell death